Blood Pressure Monitoring Devices Market to Register a CAGR of ~10.01% by 2032, Boosted by FDA Clearance of Apple's Hypertension Detection Feature | DelveInsight

The blood pressure monitoring devices market is poised for significant growth, driven by the rising global prevalence of hypertension, lifestyle-related risks, and the growing focus on early detection and preventive care. As cardiovascular diseases remain the leading cause of death worldwide, demand for accurate and user-friendly monitoring solutions-ranging from traditional cuffs to digital and wearable devices-is increasing across hospitals, clinics, home care, and remote monitoring settings.
In a landmark development, the FDA cleared Apple's new hypertension detection feature on September 12, 2025. This breakthrough approval allows Apple to introduce blood pressure monitoring capabilities on Apple Watch Series 9, Series 10, Series 11, and the premium Ultra 2 and Ultra 3 models globally before the end of September. The feature leverages the optical heart sensor to assess vascular response and provides long-term monitoring by collecting data continuously over 30-day periods. If consistent signs of hypertension are detected, users are notified and prompted to validate the findings with a traditional blood pressure cuff and seek medical advice. This innovation represents a transformative step in integrating consumer technology with clinical-grade health monitoring, potentially reshaping patient engagement and early hypertension management.

Beyond consumer tech integration, advances such as wireless cuffs, connected apps, AI-powered analytics, and cloud-enabled platforms are enabling personalized hypertension management while reducing the burden on healthcare systems. The shift toward value-based care models, combined with the rising penetration of telehealth, is further accelerating adoption.

Supported by ongoing R&D investments, strategic partnerships between medtech and digital health companies, and the expansion of healthcare infrastructure across emerging markets, the blood pressure monitoring devices market is projected to maintain steady growth momentum through 2032 at a CAGR of ~10.01%.

DelveInsight's Blood Pressure Monitoring Devices Market Insights [https://www.delveinsight.com/report-store/blood-pressure-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr] report provides an in-depth evaluation of market trends, key growth drivers, barriers, regulatory developments, the competitive landscape, and profiles of leading players shaping the future of hypertension management.

Key Takeaways from the Blood Pressure Monitoring Devices Market Report

- The global blood pressure monitoring devices market is projected to grow at a 10.01% CAGR, rising from USD 2.84 billion in 2024 to USD 6.09 billion by 2032.

- As per DelveInsight estimates, North America is anticipated to dominate the global Blood Pressure Monitoring Devices market during the forecast period.

- Notable Blood Pressure Monitoring Devices companies such as Koninklijke Philips N.V., General Electric Company, A&D Company, Hill-Rom Services Inc., American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF HEALTH PRODUCTS INC, Microlife Corporation, Rossmax International Ltd, OMRON Healthcare Inc., SCHILLER AG, Contec, Spengler, ICU Medical Inc., B. Braun Melsungen AG, Biobeat, Aktiia SA, Caretaker LLC, and several others are currently operating in the Blood Pressure Monitoring Devices market.

- In September 2025, the FDA cleared Apple's new hypertension detection feature, showcased at its September 9 event with the iPhone Air. Rolling out globally by the end of the month on Apple Watch Series 9, 10, 11, and Ultra 2 and 3, the feature uses the optical heart sensor to monitor blood vessel responses over 30 days and alerts users of potential high blood pressure. If notified, users should track their blood pressure with a cuff for seven days and consult a doctor.

- In July 2025, Aktiia received FDA 510(k) clearance for over-the-counter use of its G0 cuffless blood pressure monitoring system. This marks the first FDA clearance of a cuffless blood pressure monitor for OTC use in the U.S., with consumer availability planned for 2026.

- In January 2025, the FDA cleared Biobeat Technologies Ltd.'s BB-613-BPM Patch, a wearable device that tracks blood pressure changes using Pulse Wave Transit Time (PWTT). This device requires calibration with an FDA-cleared oscillometric monitor and provides 24-hour monitoring with user-initiated measurements every 15 minutes. Data collected can be accessed via the Biobeat platform for healthcare professionals to review.

To read more about the latest highlights related to the Blood Pressure Monitoring Devices market, get a snapshot of the key highlights entailed in the Global Blood Pressure Monitoring Devices Market Report [https://www.delveinsight.com/report-store/blood-pressure-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Blood Pressure Monitoring Devices Overview

Blood pressure monitoring devices are essential tools used to measure and track an individual's blood pressure, helping detect and manage conditions like hypertension. These devices range from traditional manual sphygmomanometers used in clinical settings to automated digital monitors for home use, offering convenience and real-time tracking for patients. Some modern devices also feature Bluetooth connectivity, enabling data sharing with healthcare providers.

With advancements in wearable technology, blood pressure monitoring is expanding beyond conventional cuffs. Smartwatches and fitness trackers, like the Apple Watch, are increasingly incorporating features that detect trends in blood pressure using optical sensors and AI algorithms. While these wearables don't replace medical-grade devices, they offer early alerts and encourage users to seek medical advice, supporting proactive health management.

Blood Pressure Monitoring Devices Market Insights

North America is expected to lead the global blood pressure monitoring devices market in 2024, holding around 35% of the share. This dominance is driven by the high prevalence of hypertension and cardiovascular diseases, strong adoption of digital and wearable monitoring technologies, and the presence of major market players. In the U.S. alone, over 119 million adults (48.2%) have high blood pressure, and millions more are affected by atherosclerotic cardiovascular disease, highlighting the urgent need for accurate, regular monitoring.

Rising healthcare spending, awareness of preventive care, and increased product innovation-such as Joytech Healthcare's FDA-cleared digital monitor in February 2024-are further fueling market growth in the region.

To know more about why North America is leading the market growth in the Blood Pressure Monitoring Devices market, get a snapshot of the Blood Pressure Monitoring Devices Market Outlook [https://www.delveinsight.com/report-store/blood-pressure-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Blood Pressure Monitoring Devices Market Dynamics

The blood pressure monitoring devices market is expanding rapidly due to rising global cases of hypertension and cardiovascular diseases. With an estimated 1.29 billion adults affected by hypertension and 26 million cases of atherosclerotic cardiovascular disease in key markets (2023), demand for regular monitoring-via home-use, wearable, and clinical devices-is increasing. Innovations like OMRON's AI-powered monitors that detect atrial fibrillation further boost market growth. However, challenges remain, including concerns over device accuracy, regulatory hurdles, high costs, and user errors, all of which can impact reliability and accessibility, especially in low-resource settings.

Get a sneak peek at the Blood Pressure Monitoring Devices market dynamics @ https://www.delveinsight.com/report-store/blood-pressure-monitoring-devices-market [https://www.delveinsight.com/report-store/blood-pressure-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Coverage: Global

Study Period: 2022 to 2032

Blood Pressure Monitoring Devices Market CAGR: ~10.01%

Key Blood Pressure Monitoring Devices Companies: Koninklijke Philips N.V., General Electric Company, A&D Company, Hill-Rom Services Inc., American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF HEALTH PRODUCTS INC, Microlife Corporation, Rossmax International Ltd, OMRON Healthcare Inc, SCHILLER AG, Contec, Spengler, ICU Medical Inc, B. Braun Melsungen AG, Biobeat, Aktiia SA, Caretaker LLC, and others.

Blood Pressure Monitoring Devices Market Segmentation

Market Segmentation By Product Type: Digital/Automated Blood Pressure Monitors {Wearable Blood Pressure Monitors, Upper Arm-based Blood Pressure Monitors, Wrist-based Blood Pressure Monitors, and Finger-based Blood Pressure Monitors} and Manual Blood Pressure Monitors {Mercury Blood Pressure Monitors and Aneroid Blood Pressure Monitors}.

Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers, Home-Care Settings, and others.

Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.

Which MedTech key players in the Blood Pressure Monitoring Devices market are set to emerge as the trendsetter, explore @ Blood Pressure Monitoring Devices Companies [https://www.delveinsight.com/report-store/blood-pressure-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Table of Contents

1. Electrophysiology Devices Market Report Introduction

2. Electrophysiology Devices Market Executive Summary

3. Competitive Landscape

4. Regulatory Analysis

5. Electrophysiology Devices Market Key Factors Analysis

6. Electrophysiology Devices Market Porter's Five Forces Analysis

7. Electrophysiology Devices Market Layout

8. Electrophysiology Devices Market Company and Product Profiles

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

Media Contact
Company Name: DelveInsight
Contact Person: Jatin Vimal
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=blood-pressure-monitoring-devices-market-to-register-a-cagr-of-1001-by-2032-boosted-by-fda-clearance-of-apples-hypertension-detection-feature-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.